8.23
Personalis Inc stock is traded at $8.23, with a volume of 861.06K.
It is up +1.35% in the last 24 hours and up +40.68% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$8.12
Open:
$8.33
24h Volume:
861.06K
Relative Volume:
0.89
Market Cap:
$729.81M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-3.6578
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
+14.31%
1M Performance:
+40.68%
6M Performance:
+151.30%
1Y Performance:
+74.00%
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
8.23 | 720.06M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.58 | 198.17B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.14 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
633.32 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
138.23 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
203.77 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-15-25 | Initiated | Guggenheim | Buy |
Mar-17-25 | Initiated | Craig Hallum | Buy |
Feb-06-23 | Upgrade | Needham | Hold → Buy |
Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-03-21 | Downgrade | Needham | Buy → Hold |
Oct-15-21 | Resumed | Cowen | Outperform |
Sep-20-21 | Reiterated | Needham | Buy |
May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
Jan-28-21 | Initiated | Truist | Buy |
Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
Nov-12-20 | Reiterated | Needham | Buy |
Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
Oct-19-20 | Initiated | Citigroup | Buy |
Oct-08-20 | Initiated | BTIG Research | Buy |
Aug-27-20 | Initiated | H.C. Wainwright | Buy |
Aug-18-20 | Initiated | Needham | Buy |
Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-15-19 | Initiated | BofA/Merrill | Neutral |
Jul-15-19 | Initiated | Cowen | Outperform |
Jul-15-19 | Initiated | Morgan Stanley | Overweight |
Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Real time scanner hits for Personalis Inc. explainedCPI Data & Safe Capital Growth Tips - newser.com
Why Personalis Inc. stock remains on watchlistsJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Will Personalis Inc. stock see PE expansion2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Will Personalis Inc. see short term momentumChart Signals & AI Enhanced Trading Signals - newser.com
Is Personalis Inc. stock ready for breakoutMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Will breakout in Personalis Inc. lead to full recoveryWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Will Personalis Inc. stock gain from government policiesPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com
Price momentum metrics for Personalis Inc. explainedQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Analyzing net buyer seller activity in Personalis Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Will Personalis Inc. benefit from macro trends2025 Pullback Review & AI Powered Market Trend Analysis - newser.com
Personalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Visual trend scoring systems applied to Personalis Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com
Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com
Personalis, Inc. Hits New 52-Week High of $8.70, Up 557.58% - Markets Mojo
Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com
What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com
Analyzing Personalis Inc. with risk reward ratio chartsDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Personalis (NASDAQ:PSNL) Reaches New 1-Year HighHere's What Happened - MarketBeat
Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World
Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st
What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in
Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com
Why Personalis Inc. stock could be next big winner2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Will Personalis Inc. stock outperform tech sector in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Personalis (NASDAQ:PSNL) Trading 8.9% HigherStill a Buy? - MarketBeat
Volume spikes in Personalis Inc. stock – what they meanJuly 2025 Action & Free Long-Term Investment Growth Plans - newser.com
What drives Personalis Inc stock priceSwing Trading Watchlist & Identify Winning Stocks - earlytimes.in
Goldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (NASDAQ:PSNL) Upgraded at Wall Street Zen - MarketBeat
Personalis (NASDAQ:PSNL) Trading 7.5% HigherHere's Why - MarketBeat
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):